New Diarylamine KV10.1 Inhibitors and Their Anticancer Potential.
Gubič Š, Toplak Ž, Shi X, Dernovšek J, Hendrickx LA, Pinheiro-Junior EL, Peigneur S, Tytgat J, Pardo LA, Peterlin Mašič L, Tomašič T.
Gubič Š, et al. Among authors: shi x.
Pharmaceutics. 2022 Sep 17;14(9):1963. doi: 10.3390/pharmaceutics14091963.
Pharmaceutics. 2022.
PMID: 36145712
Free PMC article.